Table 5.
Compound concentration | Phagocytosis capacity |
|||
---|---|---|---|---|
trisindoline 1 | trisindoline 3 | trisindoline 4 | doxorubicin | |
0 μg/mL | 31.83 ± 4.01c | 33.17 ± 1.18b | 21.33 ± 5.24a | 44.17 ± 1.18c |
6.25 μg/mL | 58.33 ± 2.35c | 59.00 ± 0.95b | 23.44 ± 7.16a | 9.11 ± 2.79ab |
12.5 μg/mL | 21.16 ± 1.18b | 16.50 ± 1.65a | 21.89 ± 1.68a | 15.64 ± 7.89ab |
25 μg/mL | 9.00 ± 0.94a | 13.00 ± 2.36a | 17.33 ± 2.90a | 17.71 ± 3.44b |
50 μg/mL | 11.50 ± 0.24a | 10.67 ± 1.41a | 32.89 ± 1.49a | 3.53 ± 0.91a |
Note: Different superscripts in the same column showed significant differences (p < 0.05).